Molecular Diagnostics at the Point of Care Market Report 2023: New Genotypes Creating New Markets - ResearchAndMarkets.com
2023-01-09
诊断试剂
DUBLIN--(BUSINESS WIRE)--The "Molecular Diagnostics at the Point of Care: By Application, Technology, Place, Product and by Country, with COVID-19 PoC Breakout and Executive Guides" report has been added to ResearchAndMarkets.com's offering.
'Molecular Diagnostics at the Point of Care: By Application, Technology, Place, Product and by Country, with COVID-19 PoC Breakout and Executive Guides'
The COVID-19 pandemic is ushering in a new world of point of care diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Point of Care testing move into the Physician's Office or even the Home? How much Covid-19 testing is being done at the Point of Care?
Point of Care testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.
Market Dynamics
Market Drivers
New Genotypes Creating New Markets
Aging Population a Boon for All Diagnostics
Developing World Driving ID Dx Growth
Point of Care - Why Centralization is Losing Steam
Self Testing
The Need for Speed
The COVID Pandemic
Market Limitations
Lower Costs
Infectious Disease is Declining
Wellness Hurts
Economic Growth improves Living Standards
Key Topics Covered:
1 Market Guides
2 Introduction and Market Definition
3 The Infectious Diseases - Market Analysis by Disease
3.1 HIV - Human Immunodeficiency Virus (AIDS)
3.4 HPV - Human papillomavirus
3.5 Influenza
3.6 CTGC - Chlamydia/Gonorhea
3.7 Tuberculosis
3.8 MRSA - Methicillin-resistant Staphylococcus aureus
3.9 VRE - Vancomycin-resistant Enterococcus
3.10 Blood Screening
3.11 COVID-19
3.12 Pandemic Diagnostics
4 Industry Overview
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Distributor and Reagent Supplier
4.1.5 Independent Testing Lab
4.1.6 Public National/regional lab
4.1.7 Hospital lab
4.1.8 Physician Office Labs and Clinics
4.1.9 Audit Body
4.1.10 Certification Body
4.2 The Clinical Laboratory Market Segments
4.2.1 Traditional Market Segmentation
4.2.2 Laboratory Focus and Segmentation
4.3 Industry Structure
4.3.1 Hospital Testing Share
4.3.2 Economies of Scale
4.3.2.1 Hospital vs. Central Lab
4.3.3 Physician Office Lab's
4.3.4 Physician's and POCT
5 Profiles of Key MDx Companies
6 Market Trends
7 Molecular Dx - Infectious Disease Recent Developments
8 The Global Market for Molecular Diagnostics at the Point of Care
9 Global MDx at the Point of Care Markets - By Application
9.1 COVID-19
9.5 Other Application
10 Global MDx Markets at the Point of Care - by Technology
10.1 PCR
10.2 NGS/Probe
10.3 Other Technology
11 Global MDx at the Point of Care Markets - by Place
11.1 Hospital Point of Care
11.2 Clinic or Physician Office Lab
11.3 Seniors Facility
11.4 Other Place
12 Global MDx at the Point of Care Markets - by Product
12.1 Instrument
12.2 Cartridge
12.3 Other Product
Companies Mentioned
Applied BioCode
Becton, Dickinson and Company
Cepheid (now Danaher)
Chembio
Cue Health
Curetis N.V./Curetis GmbH
Diascopic
Fluxergy
Genetic Signatures
Hologic
Immunexpress
Mindray
Mobidiag
Perkin Elmer
Primerdesign
Quidel
Saw Diagnostics
Seegene
Siemens Healthineers
Sona Nanotech
Vir
For more information about this report visit https://www.researchandmarkets.com/r/z37276
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。